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Abstract
Background: Minor alleles of the human dopamine receptor polymorphisms, DRD2/TaqI A and
DRD4/48 bp, are related to decreased functioning and/or numbers of their respective receptors
and have been shown to be correlated with body mass, height and food craving. In addition, the 7R
minor allele of the DRD4 gene is at a higher frequency in nomadic compared to sedentary
populations. Here we examine polymorphisms in the DRD2 and DRD4 genes with respect to body
mass index (BMI) and height among men in two populations of Ariaal pastoralists, one recently
settled (n = 87) and the other still nomadic (n = 65). The Ariaal live in northern Kenya, are
chronically undernourished and are divided socially among age-sets.
Results: Frequencies of the DRD4/7R and DRD2/A1 alleles were 19.4% and 28.2%, respectively
and did not differ between the nomadic and settled populations. BMI was higher in those with one
or two DRD4/7R alleles in the nomadic population, but lower among the settled. Post-hoc analysis
suggests that the DRD4 differences in BMI were due primarily to differences in fat free body mass.
Height was unrelated to either DRD2/TaqI A or DRD4/48 bp genotypes.
Conclusion: Our results indicate that the DRD4/7R allele may be more advantageous among
nomadic than settled Ariaal men. This result suggests that a selective advantage mediated through
behaviour may be responsible for the higher frequency of the 7R alleles in nomadic relative to
sedentary populations around the world. In contrast to previous work, we did not find an
association between DRD2 genotypes and height. Our results support the idea that human
phenotypic expression of genotypes should be rigorously evaluated in diverse environments and
genetic backgrounds.
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Background
Genetic variations in the dopamine (DA) system have
been related to nutritional indices [1-11] and a nomadic
lifestyle [12]. While human neurological, behavioural and
physiological genetics is a vast field, little such research
has been conducted among people living in non-industri-
alized or subsistence environments. Such environments
may be more similar to the environments where much of
human genetic evolution took place; indeed, they may be
adaptively relevant environments [AREs; [13]] for the evo-
lution of dopamine gene polymorphisms that have been
primarily investigated in industrialized settings. Here we
examine the relationships between genetic polymor-
phisms of dopamine receptor genes and several pheno-
types in Ariaal men.
The Ariaal are traditionally nomadic pastoralists living in
northern Kenya. They are mainly a subsistence population
with low percent body-fat and chronic under-nutrition
[14]. Roughly half of our sample consists of nomads,
while the other half are from a group that has been settled
for about 35 years and practices some agriculture [15,16].
This contrast between nomadic and settled Ariaal groups
provides an opportunity to test for gene by environment
interactions across two environments inhabited by genet-
ically and culturally similar peoples. We examine how two
dopamine receptor genetic polymorphisms relate to
measures of nutrition/body composition among these
two groups. To the best of our knowledge, this is the first
study to examine correlates of dopamine genetic variation
in a subsistence society.
Dopamine gene polymorphisms and their correlates
This study analyzes the correlates of two genetic polymor-
phisms, the TaqI A polymorphism in the dopamine recep-
tor D2 (DRD2) gene and the 48 base pair (bp) repeat
polymorphism in the dopamine receptor D4 (DRD4)
gene. There is evidence that minor alleles of both DRD2
and DRD4 (A1 and 7R respectively) decrease the sensitiv-
ity and/or concentrations of their respective receptors [17-
24]. Thus, minor alleles can be viewed as analogous to
their respective dopamine receptor antagonists (although
this neglects developmental effects), and thus provide nat-
ural experiments to dissect aspects of human physiology.
DRD2 and DRD4 are both considered D2-like receptors
and have similar functions and distributions, but are dis-
tinct. DRD2 seems to be particularly important in the
striatum, whereas DRD4 appears more important in the
prefrontal cortex [reviewed in [25]]. Both are likely
involved in impulsivity, reward anticipation and addic-
tion and they may interact in a complex manner to effect
phenotypes [reviewed in [25,26]].
The DRD4/48 bp polymorphism has been associated with
body mass index [BMI = weight in kg/height in meters^2;
[9-11], however [27]] and food craving [28]. The allele fre-
quencies of DRD4/48 bp vary considerable across popula-
tions and the 7R minor allele is generally at a higher
frequency in populations that have migrated farther or are
nomadic rather than sedentary [12] and among individu-
als with multi-racial ancestries [29]. It appears that the 7R
allele emerged and began being positively selected for
about 45,000 years ago [30].
The A1 allele of the DRD2/TaqI A polymorphism has
often been associated with substance abuse [18]. The
DRD2 gene has also been variously related to BMI and
related indices of metabolic syndrome [1-8,31]. Lower
striatal D2 receptor availability has been related to obesity
and increased BMI [32]. Those with DRD2 A1 alleles have
higher food reinforcement (are willing to work harder for
food) and consume more food than their counterparts
without A1 alleles [33,34], suggesting DRD2 impacts
nutritional status through food craving behaviour.
Increases in height have been reported among children
who were exposed pre- or post-natally to D2 receptor
blocking drugs [reviewed in [35]]. Additionally, among
four independent sets of subjects DRD2 polymorphisms
were related to height [35-37].
Predictions and findings
Based on past research suggesting that BMI associations
with dopamine receptor polymorphisms are due to
increased food craving [36,38], we expected that BMI
would be related to dopamine receptor genotype. How-
ever, food craving in western environments of plenty
might have very different implications than among under-
nourished Ariaal men. Based on observations that
nomads around the world have higher DRD4/7R allele
frequencies relative to settled populations [12], we pre-
dicted that 7R+ nomads would have better relative indices
of nutrition than 7R+ settled Ariaal.
We compared allele frequencies between the settled and
nomadic men, but due to the settled group's recent forma-
tion [15] and continued gene flow with the nomads, we
did not have clear expectations for allele frequency differ-
ences.
We also expected that DRD2 would be associated with
height as shown in previous research. Since height is a key
variable in calculating BMI and DRD2 and DRD4 are
functionally related, height was examined in relation to
both DRD2 and DRD4.
We found that BMI was higher in individuals with one or
two 7R alleles in the nomadic population, but was lower
in settled individuals with the 7R allele. Post-hoc analysis
suggests that these DRD4-related differences in BMI wereBMC Evolutionary Biology 2008, 8:173 http://www.biomedcentral.com/1471-2148/8/173
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mainly due to differences in fat free mass. Height was
unrelated to dopamine genetic polymorphisms.
Results and Discussion
Allele and genotype frequencies in nomadic and settled 
men
DRD4 allele and genotype frequencies are shown in Table
1. Settled and nomadic Ariaal did not differ in their 7R
allele frequencies (Pearson chi-square = 0.26, df = 1, p =
0.610) nor were there significant differences in overall
allele frequencies (Fisher's exact test, p = 0.906). The
DRD4 genotype frequencies of the settled and nomadic
Ariaal pooled together were in Hardy-Weinberg equilib-
rium (HWE; Markov Chain algorithm, p = 0.124) as well
as in the nomads alone (p = 0.735). The DRD4 genotype
frequency among settled Ariaal was slightly out of HWE
(Markov Chain algorithm, p = 0.036), but when the single
5R/5R individual was excluded from the analysis, HWE
was maintained (p = 0.425). No 2R alleles, the third most
common and likely functionally distinct allele, were
found in either the nomadic or sedentary samples; con-
sistent with a lack of 2R alleles in some other African pop-
ulations [39]. DRD2 allele and genotype frequencies are
shown in Table 2. The DRD2 genotype frequencies of the
settled and nomadic Ariaal pooled together was in HWE
(Fisher's exact test, p = 0.554) as well as for the settled
(Fisher's Exact, p = 0.135) and nomadic groups separately
(Fisher's Exact, p = .526).
Body Composition/Nutritional Status
Descriptions of the anthropometric variables used in this
study, including BMI and height, are given in Table 3 for
the pooled population and two sub-populations. The
nomadic and settled groups of men that make up the sam-
ple are on average underweight, having BMIs below the
18.5 standard of normal-weight [40,41]. General Linear
Models to evaluate the relation of DRD2 and DRD4 with
anthropometrics first included DRD2, DRD4, residence
and all two-way interactions and then, in a separate
model, included variables shown in past studies to be
associated with the anthropometric measure of interest
[14,42,43]. As can be seen in Models 1 & 2 of Table 4, a
strong interaction between DRD4 and residence with BMI
was evident. The nature of this interaction between DRD4
and residence is illustrated in Figure 1, where among
nomads 7R+ was related to being less underweight
(higher BMI), but among settled men, 7R+ individuals
were more underweight (lower BMI).
Height did not show the predicted association with
DRD2, nor was height associated with DRD4 (Table 4;
Models 3 and 4). Closer examination of the only other
study specifically testing for an association between
DRD2/TaqI A and height suggests that the A1 allele may
differ in its linkages in different populations. In that
study, idiopathic short stature was associated with A1 alle-
les in Japanese subjects [37]. Increases in height have been
reported among children who were exposed pre or post-
natally to D2 receptor blocking drugs [reviewed in [35]].
However, the A1 allele of the DRD2/TaqIA polymorphism
is generally associated with decreased DRD2 functioning/
expression [reviewed in [25]], so together with the D2
receptor blocking studies, we should expect A1 alleles to
be associated with increased (not decreased) height. Since
the A1 allele is not thought to be a functional polymor-
phism in the dopamine system (elaborated in the meth-
Table 1: Allele and genotype frequencies for DRD4/48 bp 
polymorphism.
All Settled Nomadic
A l l e l e / G e n o t y p e n% n% n%
Allele
4 232 76.3 130 74.7 102 78.5
5 3 1.0 2 1.1 1 0.8
6 4 1.3 2 1.1 2 1.5
7 5 91 9 . 4 3 62 0 . 7 2 31 7 . 7
8 2 0.7 1 0.6 1 0.8
1 0 41 . 3 31 . 7 10 . 8
Total 304 100.0 174 100.0 130 100.0
Genotype Classification
4 / 4 8 95 8 . 6 4 95 6 . 3 4 06 1 . 5
4/5 1 0.7 0 0.0 1 1.5
4/6 4 2.6 2 2.3 2 3.1
4 / 7 4 52 9 . 6 2 83 2 . 2 1 72 6 . 2
4/8 1 0.7 0 0.0 1 1.5
4 / 1 0 32 . 0 22 . 3 11 . 5
5/5 1 0.7 1 1.1 0 0.0
7/7 6 3.9 3 3.4 3 4.6
7/8 1 0.7 1 1.1 0 0.0
7 / 1 0 10 . 7 11 . 1 00 . 0
7- 99 65.1 54 62.1 45 69.2
7+ 53 34.9 33 37.9 20 30.8
Total 152.0 100.0 87.0 100.0 65.0 100.0
Table 2: Allele and genotype frequencies for the DRD2/TaqI A 
polymorphism.
All Settled Nomadic
Allele/Genotype n % n % n %
Allele
A1 88 28.2 53 30.5 35 25.4
A2 224 71.8 121 69.5 103 74.6
Total 312 100 174 100 138 100
Genotype Classification
A1/A1 14 9.0 11 12.6 3 4.3
A 1 / A 2 6 03 8 . 5 3 13 5 . 6 2 94 2 . 0
A 2 / A 2 8 25 2 . 6 4 55 1 . 7 3 75 3 . 6
A 1 + 7 44 7 . 4 4 24 8 . 3 3 24 6 . 4
A 1 - 8 25 2 . 6 4 55 1 . 7 3 75 3 . 6
Total 156.0 100.0 87.0 100.0 69.0 100.0BMC Evolutionary Biology 2008, 8:173 http://www.biomedcentral.com/1471-2148/8/173
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ods section), varying genetic background (i.e. different
patterns of linkage with actual functional genetic poly-
morphisms) could explain varying results across popula-
tions.
Since BMI is a coarse measure of body composition we
conducted further post-hoc analysis in an effort to under-
stand the associations of DRD4 with body composition at
a finer level. We analyzed upper arm muscle area plus
bone area (AMPBA) because it represents short term
energy balance/storage [44] and low values of AMPBA in
the elderly are associated with increased mortality [45],
triceps skinfold (TSK) as a measure of energy stores and
current energy balance [44], percent body fat (%BF) as a
measure of general adiposity, fat free mass (FFM) as
another measure of body size, and suprailliac skinfold
(SSK) as a measure of abdominal fat, thought to be the
most metabolically active fat depot [46].
AMPBA might be associated with DRD4 and DRD2
through interactions with residence, although the effect
significance depends on the other covariates in the mod-
els (Table 4, Models 5 and 6). Nomads with 7R alleles had
higher AMPBA, whereas little or no difference was found
in settled individuals (Figure 2). Based on an expectation
of similar effects of DRD2 and DRD4 minor alleles, it is
peculiar that the DRD2 A1+ genotype was near signifi-
cantly associated with decreased AMPBA among the
nomads (Figure 3). Perhaps this can be understood as
effects of DRD2 on GH and IGF-1 mediated muscle for-
mation [37,47] or maintenance [48,49]. However, such
an explanation of DRD2's effect on AMPBA is not consist-
ent with our suggested explanation for the lack of associa-
tion of DRD2 with height.
In models 7–9, 12 & 13 (Table 4), we show that TSK, %BF
and SSK were not related to DRD2 or DRD4 genotypes.
However, models 10 & 11 (Table 4), show a relatively
strong association between the interaction of DRD4 and
residence with fat free mass (FFM). Inclusion of addi-
tional relevant covariates increases the significance of this
interaction and the explanatory power of the model
(adjusted r2). The direction of the association with FFM
(Figure 4) was the same as with BMI (Figure 1); nomads
with 7R alleles had higher FFM than their nomadic coun-
terparts without 7R alleles, and the effect of DRD4 was
reversed and of a lesser magnitude among the settled.
Since FFM has previously been shown to vary with age
group [Table 4, Model 11; [42]], we additionally checked
for DRD4 by age group and DRD4 by residence by age
group interactions, but these were not evident (not
shown).
Table 5 is provided to explore the inheritance patterns
(e.g. recessive, dominant, additive or other) of the associ-
ations of DRD4 with BMI and FFM. The association of
DRD4 with BMI seems to exhibit an additive relationship;
as the number of 7R alleles increases from zero 7R alleles
(7R-/7R-), to one 7R allele (7R/7R-), to two (7R/7R), BMI
decreases in the settled men, but increases in the nomads.
FFM, which was more closely related to DRD4, does not
exhibit as clear a trend. This analysis is obviously limited
by the low sample sizes, especially among 7R homozy-
gotes.
DRD4 7R+ seems to increase total non-fat mass (FFM) of
the body, but only among nomads. FFM is defined as bod-
yweight minus body-fat weight and thus primarily meas-
ures the sum of the masses of muscle, bone, and organs.
With this exclusion of fat mass, FFM represents the more
metabolically active body portions [50]. FFM is a general
Table 3: Descriptions of phenotype variables. Abbreviations are 
defined in list of abbreviations.
All Settled Nomadic
Phenotype mean SD Mean SD Mean SD
n 152 87 65
Age 46.85 16.49 47.22 16.46 46.35 16.65
BMI 17.77 1.95 17.99 2.15 17.48 1.63
Height (cm) 172.32 6.63 172.20 6.69 172.47 6.60
AMPBA 37.46 6.26 37.49 6.10 37.42 6.50
TSK 4.85 1.79 4.95 2.04 4.73 1.39
% BF 9.62 3.12 9.67 3.26 9.54 2.97
FFM (kg) 47.45 5.49 47.76 5.58 47.04 5.39
SSK 4.72 2.11 5.11 2.65 4.19 0.75
Body Mass Index by residence and DRD4 genotype Figure 1
Body Mass Index by residence and DRD4 genotype. 
*Residence × DRD4 interaction significant (Table 4).
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index of body-size and in a chronically underweight pop-
ulation, can reasonably be assumed to represent greater
body-size and/or greater muscular and bone mass. How-
ever, given the lack of association of DRD4 with height,
the latter suggestion of increased muscle and bone mass
seems more likely. In an undernourished population with
low % body fat (Table 3), increased muscle and bone
mass might actually represent less starvation induced
breakdown of muscle mass and higher nutrient stores
(perhaps due to nutritional protein deficiency) [51].
The finding that the 7R allele had a positive association
with BMI, FFM and AMPBA among nomads, but a nega-
tive one among settled individuals is consistent with past
findings of higher 7R allele frequencies in nomadic popu-
lations around the world [12]. While dopaminergic path-
ways clearly are involved in food craving (see above), the
significance of increased food cravings is unclear in a
nutrient poor environment, where food to satisfy such
cravings is not readily available. That 7R alleles are associ-
ated with selfishness [52] might also mean that while
craving food more those 7R men are also less likely to
share food. However, it is unclear why food craving or
selfishness should vary in its outcome by residence among
the Ariaal.
HIV infection, common in Kenya, can cause wasting. Past
study among the Ariaal suggest low rates of condom usage
and a cultural acceptability for men to have multiple
simultaneous sexual partners [53]. Sexual behaviours
have been related to DRD4 [29,54,55] which might alter
sexually-transmitted disease risks. However, information
on HIV infection rates among the Ariaal is not available.
Increased impulsivity, ADHD-like traits, novelty-seeking
like traits [reviewed in [25]], aggression [56,57], violence
[26] and/or activity levels [58,59] may help nomads
obtain food resources, or exhibit a degree of behavioural
unpredictability [60] that is protective against interper-
sonal violence or robberies [61,62]. Increased activity lev-
els, if not resulting in increased food access, likely would
decrease nutritional stores. The 7R allele might also pro-
mote better infant survival [63-66] depending upon the
social and ecological context. Alternatively, these associa-
tions may represent some other more basic metabolic
influence of DRD4, such as regulation of physical activity
in high temperature environments [67-69]. Regardless of
the mechanism, the fact that the DRD4 7R allele remains
at relatively low frequency (less than 20%) despite indica-
tions that it contributes to improved somatic condition
among nomads, suggests that the 4R/7R polymorphism is
maintained by frequency dependent selection [62,70] (or
perhaps, but less likely heterozygote advantage [71]).
We recognize that both DRD2 and DRD4 genotypes are
sometimes parsed differently than shown here. To allow
further analysis and comparisons with other studies, we
have included the complete dataset used for this manu-
script as Additional files 1 &2. As well, full statistics, effect
sizes and observed power for models 2 and 11 from Table
4 are given in Additional files 3 and 4 respectively.
Conclusion
The DRD2 gene was not associated with height in this
non-industrialized group – at variance with four previous
studies. We note that the TaqI A polymorphism is itself
not know to be functional (see methods), so this finding
Table 4: Correlates of Body Composition (General Linear Models). Abbreviations are defined in list of abbreviations. Significant and 
near significant associations are bolded.
Model 1 2 Φ 3 4 5 678 9 1 0 1 1   Φ 12 13
Predictor BMI BMI Height Height AMPBA AMPBA TSK %BF %BF FFM FFM SSK SSK
Adj. r2 0.03 0.10 -0.02 0.03 0.02 0.01 0.01 -0.02 0.11 0.03 0.20 0.05 0.14
Residence 0.64 0.03 0.38 0.05 0.21 0.03 0.32 0.06 0.06 0.03 0.02 **7.61 4.49
DRD2 1.62 0.62 0.33 0.81 1.64 1.06 0.80 0.40 0.77 2.53 0.69 0.27 0.26
DRD4 0.09 0.12 0.73 0.84 2.22 1.13 0.46 0.32 0.07 2.06 2.09 0.55 0.78
DRD2 × DRD4 0.63 0.46 0.00 0.18 0.38 1.05 2.08 1.66 0.83 0.01 0.09 †3.42 2.19
DRD2 ×
Residence
0.48 0.98 0.25 0.02 †2.801 1.65 0.37 0.01 0.00 0.49 1.47 0.68 0.30
DRD4 ×
Residence
*5.21 **7.64 1.99 2.59 *3.921 †2.94 1.45 0.61 0.71 **7.17 ***11.64 0.07 0.34
Age Group - 1.10 - - - - - - ***6.49 - ***5.72 --
PM T - **9.42 - 1.36 - 0.75 - - 0.34 - *5.38 - ***15.65
AR - 1.21 - **9.53 -- - - 0 . 2 0 - *6.21 - *4.62
PM T × AR - †3.51 - **7.42 -- - - 0 . 1 0 - **7.12 - **7.16
†p ≤ 0.1; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001
Φ Detailed statistics for models 2 and 11 are given in additional files 3 and 4 respectively.BMC Evolutionary Biology 2008, 8:173 http://www.biomedcentral.com/1471-2148/8/173
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could be due to differences in genetic linkage by popula-
tion. Re-sequencing or more extensive haplotype analysis
of this region in this and other populations might eluci-
date the matter. Alternatively, population specific epi-
static interactions or the chronic undernutrition
experienced by the Ariaal men in this sample might alter
the relative expression/importance of DRD2 genotypes in
determining height.
We found that DRD4 7R+ genotypes were associated with
indices of better nutritional status among nomads, partic-
ularly higher fat free mass, but worse indices in the settled
individuals. This suggests that the 7R allele confers addi-
tional adaptive benefits in the nomadic compared to sed-
entary context. These benefits might be derived from
behavioural or metabolic differences between genotypes
that vary either in their physiological/psychological phe-
notypic expression or practical result by context. Future
study will be required to distinguish between potential
mechanisms involved.
In order to elucidate the current finding, future studies
among the Ariaal might look more specifically at food
intake, attention in children, mechanisms of defence of
livestock and/or activity levels. It might be that the atten-
tion spans conferred by the DRD4/7R+ genotype allow
nomadic children to more readily learn effectively in a
dynamic environment (without schools), while the same
attention span interferes with classroom learning in
Songa, the settled community. 7R+ boys might develop
into warriors (the life-stage of an Ariaal male that lies
between childhood and manhood) and men who can
more effectively defend against livestock raiders, perhaps
through a reputation of unpredictable behaviour that
inspires fear. Among 7R+ men in the settled community
of Songa, such tendencies might be less well suited to
practicing agriculture and selling goods at market. It
might also be that higher activity levels in 7R+ nomads are
translated into increased food production, while such
activity levels in settled men are a less efficient use of cal-
ories in food production.
This study highlights the importance of studying human
biology, and genetic polymorphisms in particular, in
diverse environments and among genetically distinct pop-
ulations.
Methods
Populations and Field Work
The Ariaal are pastoralists inhabiting both upland and
lowland regions in the Marsabit district of Kenya. First
appearing in oral history in the 1880s, they are derived
from a group of poor Rendille and Samburu groups who
banded together to build up their herds in the mountains.
Culturally, they still exhibit features of both Rendille and
Samburu, including Samburu age-set rituals and Rendille
annual camel blessings [15]. Ariaal derive their subsist-
ence from herding camels, cattle, goats, and sheep, which
they depend on for nutrition in the form of milk, blood,
and meat.
In August of 2005, as part of a study on male aging, Ariaal
participants were recruited from two venues: 103 men
from the settled agropastoral community of Songa and
102 nomadic males from the nomadic settlement of
Lewogoso on the Kasuit Plateau. Potential subjects were
identified by a scattershot method (no selection criteria)
in the settled and nomadic community, and the final sam-
ple stratified by ten year age groups; 20–29, 30–39, 40–
49, 50–59, 60+.
In Songa, maize and other foodstuffs make important
contributions to the diet [15]. The existence of drip-irriga-
tion supports the production of crops including oranges
that are sold in the nearby town of Marsabit, approxi-
mately 45 minutes away. Songa also includes an elemen-
tary school and a nurse's station. In the nomadic
community, Lewogoso, all eligible men were asked to par-
ticipate. Lewogoso is located approximately 45 minutes
from the Settlement of Korr and 3 hours from the town of
Marsabit by vehicle. The nearest clinic is in Ngrunit about
40 minutes away. Children do not attend elementary
school.
Interviews, assisted by trained translators in the appropri-
ate language (Samburu and/or Rendille), were conducted
Arm Muscle Plus Bone Area by residence and DRD4 geno- type Figure 2
Arm Muscle Plus Bone Area by residence and DRD4 
genotype. *Residence × DRD4 interaction significant in 
model 5, but not model 6 (Table 4).
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with each participant. Interviews focused on demographic
background, marital and reproductive history, social sup-
port and age-related quality of life outcomes. During
interviews, ages were estimated with reference to an event
calendar and age set membership, and further ambiguities
checked with local assistants [for further details see [72]].
Anthropometrics, genetic and hormone measures
Anthropometrics
Anthropometric measures included height, weight, arm,
waist and hip circumference and five skinfolds: triceps,
subscapular, midaxillary, suprailliac and periumbilical.
All anthropometric measures were taken by an experi-
enced human biologist (BC). Derived measures include %
body fat, calculated from skinfolds based on the D-W
equations [73]. Because the D-W equations are based on
a Caucasian sample, they may provide absolute values of
% body fat that are not directly comparable with other
populations. However, they should provide a relatively
consistent measure of % body fat within the study popu-
lation considered here. We also derived arm muscle plus
bone area (AMPBA), calculated as ([MUAC - (π × TCSF/
10)]2)/4 where MUAC is mid upper arm circumference in
cm and TCSF is the triceps skinfold in mm [74]. Fat free
mass (FFM) was calculated as weight * ([100 - % body
fat]/100).
Genotyping
Hair samples with roots were obtained by plucking, and
immediately placed in zip lock bags for transportation to
the lab of MDS. We obtained hair samples from 156 men,
including 87 settled and 69 nomadic men. The other men
lacked sufficient hair to obtain a sample, either because of
baldness or the fact that they had shaved their heads. Sam-
ples were stored at ambient temperature in the field and
then in a -20°C freezer until analysis. Bulbs were removed
from hairs under a dissecting microscope, and DNA was
extracted with a DNeasy Tissue Kit (Qiagen) and eluted in
200 μl of tris elution buffer.
DRD4 48 bp VNTR
The DRD4 48-bp VNTR polymorphism is in exon 3 of the
gene coding for the dopamine D4 receptor. The VNTR
polymorphism varies between 2 and 11 repeats of a simi-
lar 48 bp coding region sequence, with a tri-modal distri-
bution of 2, 4 and 7 repeat alleles (2R, 4R and 7R) in
most, but not all, populations [75]. While the functional
significance of the DRD4 VNTR polymorphism has not
been definitively characterized, long alleles (typically 7R
as opposed to 4R) might be functionally less reactive
based on in-vitro expression experiments [20-24], how-
ever much heterogeneity still exists [76-80]. Similarly, in
vivo human pharmacological studies are generally con-
sistent with the notion that 7R alleles are associated with
less responsive D4 receptors than 4R alleles [81-85].
The DRD4 48 bp VNTR locus was genotyped using an
adaptation of a previous protocol [25,86]. The PCR reac-
tion contained 1× Q-Solution (Qiagen), 1× PCR Buffer
(Qiagen), 1 μM Primer F1 (5' GCGACTACGTGGTC-
TACTCG 3'), 1 μM Primer R1 (5' AGGACCCTCAT-
GGCCTTG 3'), 200 μM dATP, dTTP, dCTP and 100 μM
dITP and dGTP, 0.3 units HotStar Taq (Qiagen), 1 to 5 μl
of DNA template, in a total volume of 10 μl. Thermocycler
conditions were: 15 min at 95° to activate the enzyme and
denature the DNA, 40 cycles of 1 minute denaturation at
94°, 1 minute annealing at 55°, 1.5 minute extension at
72°, followed by one cycle of 10 minute extension at 72°.
With these primers, a 4R PCR product is 475 bp. Samples
were visualized under UV on 2.0% ethidium bromide aga-
rose gels with a 100 bp ladder. In contrast to previous
results using this protocol [25], varying concentrations of
the DNA template did not result in allelic dropout. How-
ever, as observed previously at this locus [87] extra heter-
oduplex bands formed in several samples. To confirm that
these bands were in fact PCR artefacts, two sets of alterna-
tive primers were used under identical conditions (F2 5'
CGTACTGTGCGGCCTCAACGA 3' and R2 5'
GACACAGCGCCTGCGTGATGT 3', 705 bp product for
4R [75]; and F3 5' CTGCAGCGCTGGGAGGTG 3' and the
R1 primer above, 389 bp product for 4R).
DRD2 TaqI A
The  DRD2 TaqI A site is a single-nucleotide polymor-
phism with a major A2, and minor A1 allele. The A1+ gen-
otype (heterozygous or homozygous for A1) has been
Arm Muscle Plus Bone Area by residence and DRD2 geno- type Figure 3
Arm Muscle Plus Bone Area by residence and DRD2 
genotype. *Residence × DRD2 interaction near significant 
in Model 5 and non-significant in Model 6 (Table 4).
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most strongly associated with substance abuse, particu-
larly alcoholism, albeit with some ambiguity [18].
Although the mechanisms remain poorly understood, the
A1 allele is associated with decreases in dopamine D2
binding and glucose metabolic rates in many brain
regions [17-19]. The DRD2 TaqI A locus is 9.4 kb down-
stream from the coding region for the DRD2 gene, is not
in any known regulatory region, and has no known mech-
anism to influence DRD2 expression. The TaqI A poly-
morphism is also in a nearby kinase gene, the Ankyrin
Repeat and Kinase Domain Containing 1 (ANKK1) gene,
where it causes a Glutamate→Lysine substitution [88,89].
The results of the amino acid substitution are not known,
but could impact interactions of ANKK1 proteins with
other proteins including the dopamine D2 receptor [89].
No other polymorphism has been revealed to be in link-
age disequilibrium with TaqI A that could clearly account
for its functional associations [88,89].
DRD2 TaqI A was typed with a PCR/RFLP method [based
on [25,90]]. The PCR reaction contained 0.5 μM forward
(5' CACGGCTGGCCAAGTTGTCTA 3'), 0.5 μM reverse
primers (5' CACCTTCCTGAGTGTCATCAA3'), 1.25 mM
dNTP, 2.5 mM MgCl2, 0.5 units AmpliTaq Gold (ABI), 1×
Buffer (ABI), 2 μl DNA template in a total volume of 20
μl. Cycle conditions were: 8 min denaturation at 95°C, 40
cycles of 30 s denaturation at 94°, 30 s annealing at 55°C,
1.5 min extension at 72°C and one final extension of 7
minutes at 72°. The PCR product was digested with TaqI
enzyme (New England Biolabs) for at least two hours at
65°C and visualized under UV on a 1% ethidium bro-
mide agarose gel. The 300 bp PCR product is not cut by
the restriction enzyme in A1 homozygotes, whereas the
A2 allele yields 125 and 175 bp fragments. PCR products
for a sample of A1 homozygotes were re-digested to assure
proper genotyping.
Androgen Receptor (AR) CAG tri-nucleotide repeat
The AR CAG microsatellite was typed with a PCR mix con-
taining 1.25 μM forward primer (TCCAGAATCTGTTCCA-
GAGCGTGC) and 1.25 μM reverse primer
(GCTGTGAAGGTTGCTGTTCCTCAT), 2.5 mM dNTP, 2.5
mM MgCl2, 0.625 units AmpliTaq Gold (ABI), 1× Buffer
(ABI), 3 μl DNA template in a total volume of 25 μl. The
reverse AR primer was fluorescently labelled with GeneS-
can VIC (ABI). Cycle conditions were: 8 min denaturation
at 95°C, 40 cycles of 30 s denaturation at 95°, 30 s
annealing at 55°, 1 min extension at 72° and one final
extension of 7 minutes at 72°. PCR products were ana-
lyzed on an ABI 3100 genetic analyzer using GeneMapper
3.7 (ABI). Four random samples were sequenced for
length confirmation. The number of trinucleotide repeats
was calculated by subtracting 214 bp from the product
then dividing by three. The number of repeats ranged
from 15–34. A median split at 20 (<= 20 vs. >20) was used
for analyses as in [43].
Salivary Testosterone
Saliva samples were collected using standard methods
[91] including stimulation of saliva with Original fla-
voured Carefree gum. Morning samples were collected
within 15 minutes of 09:00 hours, while afternoon saliva
samples were collected within 15 minutes of 16:00 hours.
Sodium azide was added as a preservative and samples
were transported to the Laboratory of Reproductive Ecol-
ogy at Harvard University where they were assayed using
previously described RIA techniques [42]. The interassay
coefficient of variation was 15%. Four morning T values
and two afternoon T values were more than three SDs
Table 5: BMI and FFM by three DRD4 genotypes and settlement 
patterns.
Settled Nomadic
Genotype Measure BMI FFM BMI FFM
7R-/7R- Mean 18.23 48.22 17.25 45.98
n 5 45 44 54 5
SD 2.11 5.25 1.59 4.93
7R/7R- Mean 17.67 47.05 17.99 49.50
n 3 03 01 71 7
SD 2.26 6.36 1.75 5.93
7R/7R Mean 16.78 46.36 18.06 49.13
n 3333
SD 0.96 2.26 0.97 5.43
Fat Free Mass (in kg) by residence and DRD4 genotype Figure 4
Fat Free Mass (in kg) by residence and DRD4 geno-
type. *Residence × DRD4 interaction significant (Models 10 
& 11; Table 4).
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from their respective means, and were eliminated from
the analyses. Analyses here only use afternoon T values to
be consistent with past studies, however results were
essentially unchanged when morning T values were
included in the models instead (not shown).
Statistical Analysis
All anthropometric variables were examined for distribu-
tion normality. HW equilibriums were tested with the
HWE program [92]. All other statistical analyses were con-
ducted with SPSS 11. DRD2 HW equilibrium was tested
with Fisher's exact test and DRD4  was tested with the
Markov Chain algorithm [93]. Two-tailed p values less
than or equal to 0.05 were considered significant and val-
ues less than or equal to 0.10 were considered near signif-
icant.
Based on previous association studies, for the DRD2 TaqI
A, individuals with at least one A1 allele were designated
as A1+ and those who were homozygous for the A2 allele
were designated A1-. Similarly, DRD4 VNTR genotypes
were separated into 7R allele present (7+) and 7R absent
(7-) groups. Since we recognize that other methods of
parsing genotype groups and analyzing the data may be
legitimate and further our understanding, we have
included, as Additional file 1 and 2, the complete dataset
on which this manuscript is based. The analyses used 2
(Settled/Nomadic) × 2 (A1+/A1-) × 2 (7+/7-) General Lin-
ear Models (using GLM function in SPSS; including all
primary and 2-way effects).
When past results indicated the outcome variable of inter-
est was related to other predictor variables, another model
was built which also included the appropriate additional
variables. These other variables consisted of testosterone
level (afternoon measurement), the androgen receptor
(AR) genetic polymorphism, and age group.
List of abbreviations
%BF: Percent Body Fat; AMPBA: Arm Muscle Plus Bone
Area; AR: Androgen Receptor genetic polymorphism-CAG
trinucleotide repeat; bp: base pair; BMI: Body Mass Index
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Receptor D2; DRD4: Dopamine Receptor D4; FFM: Fat
Free Mass; GH: growth hormone; HWE: Hardy-Weinberg
Equilibrium; IGF-I: Insulin like Growth Factor I; Pm T:
Testosterone levels taken in the afternoon; Residence:
whether the subject is from a nomadic or sedentary com-
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